Phenotypic Exploration During Sensory Stimulation in an Acoustic Chamber (EMO-INTRA)

April 15, 2026 updated by: Centre Hospitalier St Anne

Exploration phénotypique en Contexte de Stimulations Sensorielles en Chambre Acoustique

An observational behavioural and neurophysiological study of the effects of controlled sensory stimulation (such as music, for example) on brain function

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

320

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • France
      • Paris, France, 75014
        • Recruiting
        • GHU Paris Sainte Anne
        • Contact:
        • Principal Investigator:
          • Estelle Pruvost-Robieux, MD, PHD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

GHU paris Sainte Anne

Description

Inclusion Criteria:

  • For patients : epilepsy
  • For healthy volunteers: age > 18 yo

Exclusion Criteria:

  • For patients and healthy volonteers : Deafness
  • For healthy volunteers : History of neurological conditions (including stroke, coma, epilepsy, neuro-inflammatory or neurodegenerative disease) or diagnosed cognitive impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Epilepsy and music
Epileptic patients (with or without mood disorders) exposed to music stimulations

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Neuronal networks
Time Frame: All along the study (8 years)
Description of the neural networks involved during exposure to sensory stimuli
All along the study (8 years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Psychologic outcome : anxiety
Time Frame: 8 years

Assessment of the Generalized Anxiety Disorder-7 (GAD7) in the exposed patients across the hospitalization :

minimum value 0; maximum 21; higher scores mean a worse outcome
8 years
Psychologic outcome 2 : depression
Time Frame: 8 years
Assessment of the Neurological Disorders Depression Inventory for Epilepsy (NDDI-E) in the exposed patients across the hospitalization : minimum value 6; maximum 24; higher scores mean a worse outcome
8 years
Quality of life measure
Time Frame: 8 years
Assessment of the QOLIE-31(quality of life in epilepsy) scale among exposed patients
8 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier St Anne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2025

Primary Completion (Estimated)

December 2, 2035

Study Completion (Estimated)

December 2, 2035

Study Registration Dates

First Submitted

April 3, 2026

First Submitted That Met QC Criteria

April 15, 2026

First Posted (Actual)

April 22, 2026

Study Record Updates

Last Update Posted (Actual)

April 22, 2026

Last Update Submitted That Met QC Criteria

April 15, 2026

Last Verified

April 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • D25-P008

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epilepsy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe